MADRID -- Extended low-dose apixaban (Eliquis) after venous thromboembolism (VTE) provoked by events like trauma or surgery in patients with obesity or other enduring risk factors dramatically reduced ...

One of Python’s most persistent limitations is how unnecessarily difficult it is to take a Python program and give it to another user as a self-contained click-to-run package. The design of the Python ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients ...

A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients ...

Samsung Medical Center announced that its researchers have developed a new AI model capable of predicting the recurrence risk of non-small cell lung cancer up to a year in advance. According to the ...

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

Please provide your email address to receive an email when new articles are posted on . Having a previous retinal event may be a risk factor for a recurrence after cataract surgery. A greater duration ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...

Encorafenib and binimetinib show promise in reducing recurrence risk for high-risk BRAF V600-mutant melanoma, demonstrating a manageable safety profile. In the intention-to-treat (ITT) population (n = ...